Health Technology Assessment Review: Exploring Consultation 2

By Danélia Botes

February 12, 2024


The Office of Health Technology Assessment Review has launched the second consultation of the Health Technology Assessment (HTA) Review, a crucial step towards improving Australia’s HTA policies and methods. This article is based on the latest HTA Review updates published early in February 2024 by the Pharmaceutical Benefits Advisory Committee (PBAC).

The Purpose and Goals of Consultation 2

The HTA Review’s Consultation 2 is a significant part of the Strategic Agreement, aimed at ensuring Australia’s assessment processes stay abreast with rapid advances in health technology. The consultation seeks to understand potential implications and identify unintended outcomes of the proposed options for reform.

The Role of the HTA Review Reference Committee

The HTA Review Reference Committee, announced by the Minister for Health in October 2022, oversees the HTA Review. The Committee plays a crucial role in developing the options paper and considering feedback from various stakeholders before finalising recommendations.

Participating in Consultation 2

Stakeholders are invited to participate through an online survey or attend workshops, either in-person or online. The consultation period is open until the end of February 2024, with workshops scheduled throughout the month.

The Scope and Impact of Consultation 2

The consultation welcomes feedback on the Options Paper in relation to the proposed HTA review scope. The outcomes of this consultation could shape the future of HTA policies and methods, potentially impacting stakeholders across the healthcare industry.


The HTA Review’s Consultation 2 is a crucial step towards improving Australia’s health technology assessment processes. The feedback and insights gained from this process will undoubtedly shape the future of healthcare in the country.

Reference url

Recent Posts

Cost and clinical impact of MIS-C

Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndrome in Children (MIS-C)

🔍 Discovering the Economic Impact of Multisystem Inflammatory Syndrome in Children (MIS-C) 🏥💰

Understanding the cost and clinical impact of MIS-C during COVID-19 is crucial for healthcare providers and policymakers. Learn about treatment costs, patient outcomes, and key statistics related with MIS-C.

🌟#Healthcare #MIS-C #COVID19 #Pediatrics #HealthEconomics #MedicalResearch #HealthcareResearch #MedicalEconomics 📊

Let’s navigate the intersection of healthcare and economics together! 💼 #HealthcareInsights #EconomicAnalysis 🧠


Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia

Hepatitis B continues to pose a significant public health challenge, but the World Health Organization continues to work towards achieving their ambition of eliminating HBV as a public health problem by 2030.

One strategy is the Treat All approach, which sounds promising – however, in low-resource settings implementing promising strategies becomes more complex. This study explores striking the balance between promising strategies and getting people the treatment they need.

Learn more about innovative HBV treatment approaches and their impact on global health. Stay informed and join the conversation! 💡🔬 #HealthcareInnovation #HBVResearch

cost effectiveness multiple sclerosis

Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis

Exploring the Cost-Utility of MS Treatments: A Comprehensive Review 🧠💼 Dive into the latest findings on the cost-effectiveness of Disease-Modifying Drugs for Multiple Sclerosis. Discover key insights and recommendations for optimizing treatment strategies. #MSresearch #HealthcareEconomics #Neurology #HealthTech 📊🔬

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.



1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA



© 2024 Syenza™. All rights reserved.